Cutting edge: The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule a independent of a disintegrin and metalloproteinases

Journal of Immunology

Volumn 184, Issue 7, 2010, Pages 3346-3350

  Liu, Gang ^a   Atteridge, Catherine L ^a   Wang, Xuanjun ^a   Lundgren, Ashley D ^a   Wu, Jennifer D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MATRIX METALLOPROTEINASE 14; PROTEIN MICA; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; MHC CLASS I RELATED CHAIN A; MHC CLASS I-RELATED CHAIN A;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; ANIMAL; CELL SEPARATION; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPRECIPITATION; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ADAM PROTEINS; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SEPARATION; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOPRECIPITATION; KILLER CELLS, NATURAL; MATRIX METALLOPROTEINASE 14; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77951629654     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903789     Document Type: Article

References (29)

1. Groh, V., R. Rhinehart, H. Secrist, S. Bauer, K. H. Grabstein, and T. Spies. 1999. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. U.S.A. 96: 6879-6884.
2. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729. (Pubitemid 129505074)
3. Groh, V., R. Rhinehart, J. Randolph-Habecker, M. S. Topp, S. R. Riddell, and T. Spies. 2001. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2: 255-260.
4. Wu, J., V. Groh, and T. Spies. 2002. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells. J. Immunol. 169: 1236-1240. (Pubitemid 34809164)
5. Nausch, N., and A. Cerwenka. 2008. NKG2D ligands in tumor immunity. Oncogene 27: 5944-5958.
6. Groh, V., J. Wu, C. Yee, and T. Spies. 2002. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419: 734-738. (Pubitemid 35177960)
7. Wu, J. D., L. M. Higgins, A. Steinle, D. Cosman, K. Haugk, and S. R. Plymate. 2004. Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J. Clin. Invest. 114: 560-568.
8. Doubrovina, E. S., M. M. Doubrovin, E. Vider, R. B. Sisson, R. J. O'Reilly, B. Dupont, and Y. M. Vyas. 2003. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J. Immunol. 171: 6891-6899.
9. Raffaghello, L., I. Prigione, I. Airoldi, M. Camoriano, I. Levreri, C. Gambini, D. Pende, A. Steinle, S. Ferrone, and V. Pistoia. 2004. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. Neoplasia 6: 558-568. (Pubitemid 39411093)
10. Märten, A., M. von Lilienfeld-Toal, M. W. Büchler, and J. Schmidt. 2006. Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing gammadelta T cell cytotoxicity. Int. J. Cancer 119: 2359-2365. (Pubitemid 44546956)
11. Jinushi, M., M. Vanneman, N. C. Munshi, Y. T. Tai, R. H. Prabhala, J. Ritz, D. Neuberg, K. C. Anderson, D. R. Carrasco, and G. Dranoff. 2008. MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma. Proc. Natl. Acad. Sci. U.S.A. 105: 1285-1290.
12. Groh, V., K. Smythe, Z. Dai, and T. Spies. 2006. Fas-ligand-mediated paracrine Tcell regulation by the receptor NKG2D in tumor immunity. Nat. Immunol. 7: 755-762.
13. Kaiser, B. K., D. Yim, I. T. Chow, S. Gonzalez, Z. Dai, H. H. Mann, R. K. Strong, V. Groh, and T. Spies. 2007. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 447: 482-486.
14. Salih, H. R., H. G. Rammensee, and A. Steinle. 2002. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J. Immunol. 169: 4098-4102.
15. Waldhauer, I., D. Goehlsdorf, F. Gieseke, T. Weinschenk, M. Wittenbrink, A. Ludwig, S. Stevanovic, H. G. Rammensee, and A. Steinle. 2008. Tumor-associated MICA is shed by ADAM proteases. Cancer Res. 68: 6368-6376.
16. Boutet, P., S. Agüera-González, S. Atkinson, C. J. Pennington, D. R. Edwards, G. Murphy, H. T. Reyburn, and M. Valés- Gómez. 2009. Cutting edge: the metalloproteinase ADAM17/TNF-alpha- converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein. J. Immunol. 182: 49-53.
17. Wang, X., A. D. Lundgren, P. Singh, D. R. Goodlett, S. R. Plymate, and J. D. Wu. 2009. An six-amino acid motif in the alpha3 domain of MICA is the cancer therapeutic target to inhibit shedding. Biochem. Biophys. Res. Commun. 387: 476-481.
18. Rubinson, D. A., C. P. Dillon, A. V. Kwiatkowski, C. Sievers, L. Yang, J. Kopinja, D. L. Rooney, M. Zhang, M. M. Ihrig, M. T. McManus, et al. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33: 401-406.
19. Wu, J. D., C. L. Atteridge, X. Wang, T. Seya, and S. R. Plymate. 2009. Obstructing shedding of the immunostimulatory MHC class I chain-related gene B prevents tumor formation. Clin. Cancer Res. 15: 632-640.
20. Vecchi, M., L. A. Rudolph-Owen, C. L. Brown, P. J. Dempsey, and G. Carpenter. 1998. Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloproteasesh RNA dependent cleavage of the ErbB-4 receptor andamphiregulin. J. Biol. Chem. 273: 20589-20595.
21. Kajita, M., Y. Itoh, T. Chiba, H. Mori, A. Okada, H. Kinoh, and M. Seiki. 2001. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 153: 893-904. (Pubitemid 34289231)
22. Essick, E., S. Sithu, W. Dean, and S. D'Souza. 2008. Pervanadate-induced shedding of the intercellular adhesion molecule (ICAM)-1 ectodomain is mediated by membrane type-1 matrix metalloproteinase (MT1-MMP). Mol. Cell. Biochem. 314: 151-159.
23. Thathiah, A., and D. D. Carson. 2004. MT1-MMP mediates MUC1 shedding independent of TACE/ADAM17. Biochem. J. 382: 363-373. (Pubitemid 39141600)
24. Velasco-Loyden, G., J. Arribas, and F. López-Casillas. 2004. The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1. J. Biol. Chem. 279: 7721-7733.
25. Osenkowski, P., M. Toth, and R. Fridman. 2004. Processing, shedding, and endocytosis ofmembrane type 1-matrixmetalloproteinase(MT1-MMP). J. Cell. Physiol. 200: 2-10.
26. Kuo, Y. C., C. H. Su, C. Y. Liu, T. H. Chen, C. P. Chen, and H. S. Wang. 2009. Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase. Int. J. Cancer 124: 2568-2576.
27. Eisele, G., J. Wischhusen, M. Mittelbronn, R. Meyermann, I. Waldhauer, A. Steinle, M. Weller, and M. A. Friese. 2006. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Brain 129: 2416-2425. (Pubitemid 44522126)
28. Arribas, J., and A. Borroto. 2002. Protein ectodomain shedding. Chem. Rev. 102: 4627-4638.
29. Poincloux, R., F. Lizárraga, and P. Chavrier. 2009. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J. Cell Sci. 122: 3015-3024.